Table 3.
Multi-attribute utility instruments (MAUIs) developed for children and tariff valuation population and method
| MAUI | Target age range | Tariff valuation population and method | Number of samples (%) |
|---|---|---|---|
| Childhood-specific MAUIs | |||
| 16D | 12–15 | Finnish schoolchildren aged 12–16 (n = 213) using VAS [18] | 68 (93.2) |
| No information or reference on tariff | 5 (6.8) | ||
| 17D | 8–11 (Proxy for < 8) | Finnish parents of children aged 8–11 (n = 115) using VAS [19] | 39 (100.0) |
| AQoL-6D | Adolescents | 1. Australian adolescents (n = 2790) using TTO [69] | 36 (72.0) |
| 2. Australian general adult public (n = 411) using TTO [70] | 14 (28.0) | ||
| CHU9D | 7–17 | 1. Australian adolescents aged 11–17 (n = 590) using best-worst scale discrete-choice experiment [71] | 91 (39.4) |
| 2. Australian adolescents aged 11–17 (n = 1982) using best-worst scale discrete-choice experiment [72] | 16 (6.9) | ||
| 3. UK general adult public (n = 300) using SG [73] | 122 (52.8) | ||
| No information or reference on tariff | 2 (0.9) | ||
| EQ-5D-Y | 8–15 (Proxy for 4–7) | 1. Canadian elementary schoolchildren aged 10–11 (n = 4485) using VAS [74] | 1 (0.9) |
| 2. UK general adult public (n = 3395) using TTO [75] | 25 (23.1) | ||
| 3. Dutch general adult public (n = 309) using TTO [76] | 9 (8.3) | ||
| 4. Dutch general adult public (n = 303) using TTO [77] | 5 (4.6) | ||
| 5. Australian general adult public (n = 417) using TTO [78] | 14 (13.0) | ||
| 6. French general adult public (n = 452) using TTO [79] | 3 (2.8) | ||
| 7. Swedish general adult public (n = 45,000) using TTO and VAS [80] | 4 (3.7) | ||
| 8. General adult public from Finland, Germany, Netherlands, Spain, Sweden and UK (n = 6870) using VAS [81] | 2 (1.9) | ||
| 9. US general adult public using TTO [82] | 23 (21.3) | ||
| No information or reference on tariff | 22 (20.4) | ||
| PAHOM | 7–13 | 1. Asthmatic children aged 6–12 (n = 261) using SG [83] | 60 (87.0) |
| 2. US general adult public (n = 94) using VAS [44] | 4 (5.8) | ||
| 3. US general adult public (n = 101) using SG [44] | 4 (5.8) | ||
| No information or reference on tariff | 1 (1.4) | ||
| CH-6D | 16–18 | No information or reference on tariff | 3 (100.0) |
| MAUIs compatible with childhood and adult populations | |||
| HUI2 | ≥ 5 (Proxy for 5–8) | 1. Canadian parents of schoolchildren (n = 194) using VAS and SG [84] | 357 (74.1) |
| 2. Canadian parents of normal children (n = 300) using VAS and SG [85] | 22 (4.6) | ||
| 3. Singaporean parents of paediatric cancer patients (n = 59) using VAS and SG [86] | 10 (2.1) | ||
| 4. Singaporean general public parents of children (n = 194) using VAS and SG [86] | 10 (2.1) | ||
| 5. UK general adult public (n = 201) using VAS and SG [87] | 58 (12.0) | ||
| No information or reference on tariff | 25 (5.2) | ||
| HUI3 | ≥ 5 (Proxy for 5–8) | Canadian general adult public (n = 504) using VAS and SG [88] | 753 (91.6) |
| No information or reference on tariff | 69 (8.4) | ||
| Modified HUI [39, 40] | N/A | 1. Canadian parents of schoolchildren (n = 194) using VAS and SG [84] | 7 (87.5) |
| 2. Canadian general adult public (n = 504) using VAS and SG [88] | 1 (12.5) | ||
| QWB | N/A | US general public (n = 800) using VAS [89] | 224 (100.0) |
| ABC-UI | N/A (Proxy completed) | UK general adult public (n = 349) using TTO [90] | 1 (100.0) |